Live Video Detailing Scores High Marks with Physicians

Manhattan ResearchThough video detailing had a rocky start when it debuted a decade ago, recent physician online video adoption and satisfaction rates indicate that this channel is now a viable option for pharma, biotech, and device manufacturers. Manhattan Research's ePharma Physician® v8.0 study found that the majority of physicians who have engaged in online video meetings with a pharma sales rep or cell center report that they are satisfied with the experience.

As part of its ePharma Physician® market research and strategic advisory service, Manhattan Research releases a new analysis, "The Evolving Market for Video Detailing: Adoption, Market Potential, and Strategic Implementation." This report includes data and insights around the current state of physician video detailing adoption, demographics, behaviors, and satisfaction; market potential and future interests; delivery models and vendors; and strategic implementation best practices. The objective of the analysis is to provide pharma, biotech, and device manufacturers with the market data and analysis for justifying strategic investment in video detailing and adapting and planning for the future of the physician-sales and company rep relationship.

"Video detailing has finally re-emerged as a viable marketing and service option, prompting manufacturers to take another look at this channel to connect with physicians," said Monique Levy, Senior Director of Research at Manhattan Research and author of the analysis. "Video detailing users are some of the industry's most valuable and tech-savvy customers. Beyond being highly adept at navigating in a multichannel environment, video detailing users are more likely to write a larger volume of scripts and to have a higher weekly patient load than non-users of video detailing."

Analysis Outline
The Evolving Market for Video Detailing: Adoption, Market Potential, and Strategic Implementation

  • Demand for Video Detailing Among U.S. Doctors
  • Profile of Video Detailing Users
  • Outlook
    • Physician Demand
    • Delivery Models and Vendor Overview
  • Strategic Implementation

For an excerpt from the analysis and more information about its contents, please visit: http://www.manhattanresearch.com/products/Research_Modules/Physician/evolving-market-for-video-detailing-pharma.aspx

About ePharma Physician® v8.0
ePharma Physician® v8.0 was conducted via online survey methodology in Q2 2008 among 1,681 online practicing U.S. physicians. The study and advisory service has determined the leading online physician destinations based on the number of physician visitors as well as the content satisfaction of those who visit and provides in-depth analysis of top product and corporate pharmaceutical websites, health portals, online journal sites, specialty-specific sites, newsletters, society sites, physicians and Web 2.0, physician online communities, electronic detailing, Tablet PCs, online conferences, physician customer service portals, tech-enabled sales forces, physician CRM, and more. For more information: http://www.manhattanresearch.com/products/Strategic_Advisory/ePP/

ePharma Physician® v8.0 reveals the relevant market share and physician satisfaction for 300+ leading pharmaceutical product websites. Broad physician research can by segmented by 25 specialist groups.

About Manhattan Research
Manhattan Research, a Decision Resources, Inc. company, is a leading market research and advisory services firm for global pharmaceutical and healthcare companies. For more information, visit http://www.manhattanresearch.com.

About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at http://www.decisionresourcesinc.com.

Most Popular Now

Salvat Laboratories announces submission of New Dr…

Salvat Laboratories announced that it has submitted a New Drug Application (NDA) to the FDA for the approval of the first ocular corticosteroid formulated in a nanoemulsi...

Pfizer's elranatamab granted FDA Breakthrough Ther…

Pfizer Inc. (NYSE:PFE) announced its investigational cancer immunotherapy, elranatamab, received Breakthrough Therapy Designation from the U.S. Food and Drug Administrati...

New insights on antibody responses to Omicron vari…

Knowing how well vaccination against one SARS-CoV-2 strain (with or without previous infection) counteracts infection with a different strain is a critical research quest...

The origin-of-life molecule, a key to cancer resea…

RNA, the molecule that gave rise to life, has been shown to be essential for repairing human genetic material and preventing mutations that might lead to developing cance...

Bayer with continued strong performance

The Bayer Group maintained its strong business performance across all three divisions in the third quarter. "Despite rising inflation and global supply chain problems, we...

Vividion Therapeutics names Jenna Goldberg as Chie…

Vividion Therapeutics, Inc., a biopharmaceutical company utilizing novel discovery technologies to unlock high value, traditionally undruggable targets with precision the...

Sugar molecules as a target in cancer therapy

Cancer cells use sugar molecules on their surface to disable attacks by the body's immune system. Researchers at the University of Basel now report on how this mechanism ...

COVID vaccination improves effectiveness of cancer…

Patients with nasopharyngeal cancer are often treated with drugs that activate their immune system against the tumor. Until now, it was feared that vaccination against Co...

Pfizer and BioNTech receive positive CHMP opinion …

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (COMIRNATY® Original/Omicron ...

Making melanoma immortal: Pitt scientists discover…

Scientists at the University of Pittsburgh School of Medicine have discovered the missing puzzle piece in the mystery of how melanoma tumors control their mortality. I...

Study reveals vaccine confidence declined consider…

A new study suggests that, despite the success of the COVID-19 vaccination campaigns, vaccine confidence has declined significantly since the start of the pandemic. Re...

New drug shows promise for fighting both COVID-19 …

While vaccination can provide life-saving protection against COVID-19, scientists are still searching for ways to treat severe infections, including in people who cannot ...